Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RAGONESE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.343
EU - Europa 11.358
AS - Asia 8.680
SA - Sud America 1.262
AF - Africa 284
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 23
Totale 40.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.998
SG - Singapore 2.972
RU - Federazione Russa 2.846
IT - Italia 2.367
CN - Cina 2.272
FI - Finlandia 1.353
DE - Germania 1.148
BR - Brasile 989
UA - Ucraina 896
HK - Hong Kong 887
VN - Vietnam 821
PL - Polonia 577
GB - Regno Unito 512
FR - Francia 439
IE - Irlanda 400
JP - Giappone 334
BD - Bangladesh 275
IN - India 220
KR - Corea 220
SE - Svezia 192
CA - Canada 160
BE - Belgio 129
IQ - Iraq 105
NL - Olanda 103
AR - Argentina 102
IR - Iran 102
RO - Romania 100
TR - Turchia 94
MX - Messico 77
AT - Austria 72
CI - Costa d'Avorio 55
ES - Italia 54
MA - Marocco 46
UZ - Uzbekistan 46
EG - Egitto 45
AU - Australia 44
PK - Pakistan 44
ZA - Sudafrica 42
ID - Indonesia 39
VE - Venezuela 35
EC - Ecuador 32
MY - Malesia 30
SA - Arabia Saudita 30
KE - Kenya 29
JM - Giamaica 27
CZ - Repubblica Ceca 26
BG - Bulgaria 25
CL - Cile 23
GR - Grecia 23
PH - Filippine 23
CO - Colombia 22
JO - Giordania 22
PY - Paraguay 20
CH - Svizzera 19
CR - Costa Rica 18
DZ - Algeria 18
KZ - Kazakistan 18
LT - Lituania 18
AE - Emirati Arabi Uniti 17
HN - Honduras 17
EU - Europa 16
NP - Nepal 15
TN - Tunisia 15
IL - Israele 14
PE - Perù 13
UY - Uruguay 12
AZ - Azerbaigian 11
BO - Bolivia 9
LB - Libano 9
NZ - Nuova Zelanda 9
AL - Albania 8
ET - Etiopia 8
GE - Georgia 8
SK - Slovacchia (Repubblica Slovacca) 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
PA - Panama 7
BY - Bielorussia 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
NG - Nigeria 6
OM - Oman 6
RS - Serbia 6
SN - Senegal 6
NI - Nicaragua 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
DK - Danimarca 4
MK - Macedonia 4
PR - Porto Rico 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CY - Cipro 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
Totale 39.950
Salva come PNG Salva come JPEG
Città #
Ashburn 2.223
Singapore 1.961
Fairfield 1.569
San Jose 1.232
Chandler 979
Woodbridge 895
Houston 884
Hong Kong 831
Ann Arbor 742
Wilmington 666
Seattle 617
Moscow 513
Cambridge 493
Zgierz 492
Jacksonville 483
Palermo 468
Dublin 390
Beijing 352
Secaucus 342
Des Moines 341
Medford 324
Santa Clara 323
Tokyo 320
Dallas 319
Los Angeles 317
Ho Chi Minh City 305
Frankfurt am Main 250
Nanjing 244
New York 239
Lauterbourg 221
Boardman 218
Princeton 206
Hefei 200
Council Bluffs 185
Altamura 169
Hanoi 169
The Dalles 154
Milan 136
Tulsa 127
Lawrence 125
Dearborn 120
Buffalo 117
Brussels 115
Helsinki 108
San Diego 96
São Paulo 93
Chicago 89
Shenyang 86
London 77
Seoul 77
Changsha 76
Jinan 72
Rome 69
Tianjin 69
Nanchang 66
Ludwigshafen am Rhein 63
Hebei 62
Abidjan 54
Atlanta 54
Jiaxing 51
Orem 51
Warsaw 50
Toronto 48
Da Nang 45
Amsterdam 44
Baghdad 42
Nuremberg 42
Venice 42
Phoenix 41
Zhengzhou 41
Haiphong 39
Seongnam 39
Tehran 39
Ningbo 38
Columbus 37
Hangzhou 37
Saint Petersburg 37
Verona 36
Kumar 35
Naples 35
Chennai 34
Montreal 34
Guangzhou 33
Tashkent 33
Brooklyn 32
Vienna 32
Washington 32
Stockholm 30
Denver 29
Johannesburg 29
Rio de Janeiro 29
Istanbul 28
Munich 28
Sydney 26
Durham 25
Norwalk 24
Belo Horizonte 23
Biên Hòa 23
Dhaka 23
Düsseldorf 23
Totale 24.026
Salva come PNG Salva come JPEG
Nome #
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study. 1.045
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 367
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 356
INCIDENCE OF AMYOTROPHIC LATERAL SCLEROSIS IN SICILY: A POPULATION BASED STUDY. 306
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis 303
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 290
Diabetic and non-diabetic subjects with ischemic stroke: Differences, subtype distribution and outcome 271
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study 270
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 267
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture 264
A population-based survey of cognitive performance in a Sicilian elderly community. 260
EARLY AND LATE MORTALITY OF SPONTANEOUS HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 257
Klotho and vitamin D in multiple sclerosis: an Italian study 257
Fumo, caffè e rischio di Sclerosi Multipla: uno studio caso-controllo 255
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 254
Age at menopause predicts age at onset of Parkinson's disease. 251
Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura 249
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 249
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 248
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 247
Height as a potential indicator of early life events predicting Parkinson's disease: a case-control study. 242
Dropped head as an unusual presenting sign of myasthenia gravis 241
The relapse rate of multiple sclerosis changes during pregnancy: a cohort study 236
Risk of Parkinson disease in women: effect of reproductive characteristics 236
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 235
Association of CYP2R1 rs10766197 with MS risk and disease progression 234
Blood Lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients 233
Frequency and Determinants for Hemorrhagic Transformation of Cerebral Infarction 229
A CASE-CONTROL STUDY ON THE ASSOCIATION BETWEEN DIABETES AND PD 228
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 228
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 226
Search for genetic factors associated with susceptibility to multiple sclerosis. 225
LEVETIRACETAM IN THE TREATMENT OF VASCULAR CHOREA: A CASE REPORT 222
Parkinson's Disease and Cancer 222
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 222
Multiple sclerosis survival: a population-based study in Sicily. 220
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex 219
Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B(12) in the acute phase of atherothrombotic stroke. 219
BODY MASS INDEX DOES NOT CHANGE BEFORE PARKINSON'S DISEASE ONSET. 218
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies 215
DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE 214
Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects. 209
Application of tRNS to improve Multiple Sclerosis Fatigue: a sham-controlled study 209
Analisi dei Polimorfismi di Citochine Th2 nella Sclerosi Multipla. 205
Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study 205
Diabetes preceding Parkinson's disease onset. A case-control study 205
Determinants of depressive symptoms among spouse caregivers of patients with Parkinson's disease 204
Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases. 204
MRI abnormalities following repeated and incoming seizures 202
A case control study to evaluate the relationship between cigarette smoking or coffee consumption and multiple sclerosis 202
Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy 202
Age at onset of parkinson's disease in women is associated with age at menopause. 199
Determinants of depressive symptoms among spouse caregivers of patients with Parkinson’s disease 199
Food of the Gods for the Treatment of Multiple Sclerosis Related Fatigue? 199
FREQUENCY AND DETERMINANTS FOR HEMORRHAGIC TRANSFORMATION OF CEREBRAL INFARCTION 198
Dropped head as an unusual presenting sign of myasthenia gravis 197
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a screening questionnaire. 197
Efficacy of 12 weeks of proprioceptive training in patients with multiple sclerosis 197
Effects of transcranial random noise stimulation combined with Graded Repetitive Arm Supplementary Program (GRASP) on motor rehabilitation of the upper limb in sub-acute ischemic stroke patients: a randomized pilot study. 193
A SPG4 GENE MUTATION CAUSES AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA IN AN ITALIAN FAMILY 191
A post-marketing comparison study on disability modification in progressive multiple sclerosis after interferon beta-1b or mitoxantrone therapy 191
Frequency and determinants for hemorrhagic transformation of cerebral infarction. 191
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. 191
Depression and associated factors among spouse-caregivers of patient with Parkinson’s disease 189
BODY MASS INDEX AND PARKINSON'S DISEASE: A CASE-CONTROL STUDY 189
remarkably increasing incidence of multiple sclerosis. A follow-up study in Caltanissetta, Sicily 189
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients 189
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 189
Extracellular vesicles from CS fluid are possible biomarkers of multiple sclerosis disease status 189
HIGH PREVALENCE AND FAST RISING INCIDENCE OF MULTIPLE SCLEROSIS IN CALTANISSETTA, SICILY, SOUTHERN ITALY. 188
Autosomal dominant hereditary spastic paraplegia: report of a large italian family with R581X spastin mutation. 187
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 187
Identification of the novel D297fsX318 PINK1 mutation and phenotype variation in a family with early onset Parkinson’s disease 185
A Door-to-Door population based survey on cognitive performance In Bagheria, Sicily. 184
Remarkably increasing incidence of Multiple Sclerosis. A follow-up study in calatanissetta, Sicily 183
Frequency and determinants for hemorragic transformation of cerebral infarction 183
Dentatorubral-pallidoluysian atrophy: Haplotype of Asian origin in 2 Italian families. 182
Tumor diagnosis preceding Parkinson's disease: a case-control study. 181
Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke : Posterior ischemic stroke and hemorrhagic transformation. 181
Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach 179
Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis 178
Further evidence of genetic heterogeneity in familial essential tremor. 177
Hypoxanthine and purine compounds in plasma from patients with multiple sclerosis and psoriasis 177
IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS 177
High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patients 176
DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE 176
Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? 175
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS 175
A new road to improve vitamin D and balance through Taopatch® and proprioceptive protocol in Multiple Sclerosis patients 175
An unexpected association between intracranial hypotension and split cord malformation 174
A population-based survey on cognitive performance in Sicily. Cognitive impairment is modified by fertile life characteristics. 174
PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY 174
CYP27A1, CYP24A1, and RXR-α Polymorphisms, Vitamin D, and Multiple Sclerosis: a Pilot Study 174
Search for genetic factors associated with susceptibility to multiple sclerosis. 173
Blood lipid, homocysteine, uric acid and vitamins in clinically stable Multiple Sclerosis patients 173
Leprosy: report of a case with severe peripheral neuropathy. 173
Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors 172
Prevalence of comorbidity in Parkinson’s disease: a case-control study 171
Frequency and determinants for hemorrhagic trasformation of cerebral infarction 171
Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease 170
Totale 22.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.240 107 538 49 83 60 68 108 118 239 287 114 469
2022/20233.509 359 512 76 297 426 538 327 289 353 57 195 80
2023/20241.824 90 239 188 153 172 296 150 129 37 60 39 271
2024/20254.421 167 377 288 389 189 131 290 232 311 470 594 983
2025/202616.323 1.215 797 955 1.447 1.398 2.377 1.920 1.674 1.199 2.047 660 634
2026/2027341 341 0 0 0 0 0 0 0 0 0 0 0
Totale 40.927